Sontra validates continuous transdermal glucose monitor in 24-hour trial
This article was originally published in Clinica
Executive Summary
Sontra Medical's continuous transdermal glucose monitor (CTGM) for use in the intensive care unit (ICU) has produced promising results in the first clinical study to verify its performance.